Biotech Patents Vulnerable? Court Ruling May Have Ripple Effect For Life Sciences Industry
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Circuit’s Bilski ruling could make some biotechnology patents vulnerable to infringement, industry group says.